SCHEMBL2400751

SCHEMBL2400751

C[N][C@H](C)c1ccccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 3/20 0.44
ADRB2 P07550 2/20 0.43
ADRB1 P08588 2/20 0.43
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
NFKB1 P19838 2/20 0.42
CYP1A2 P05177 1/20 0.42
PNMT P11086 1/20 0.42
NISCH Q9Y2I1 1/20 0.41
LMNA P02545 3/20 0.41
ALDH1A1 P00352 2/20 0.41
GLA P06280 1/20 0.41
TSHR P16473 4/20 0.39
AOC3 Q16853 1/20 0.39
HIF1A Q16665 3/20 0.38
IDO1 P14902 2/20 0.38
TDO2 P48775 2/20 0.38
IDO2 Q6ZQW0 2/20 0.38
CYP2C19 P33261 2/20 0.38
BLM P54132 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL84509 0.75 GABRA1 (0.50) ADRB2ADRB1CYP3A4CYP2D6NFKB1
SCHEMBL12204154 0.75 ADRB2 (0.48) HSD11B1ADRB2ADRB1CYP3A4CYP2D6
SCHEMBL2402392 0.74 CYP1A2 (0.39) CYP3A4CYP2D6NFKB1CYP1A2PNMT
SCHEMBL2402247 0.74 ESR1 (0.48) ADRB2CYP3A4CYP2D6ALDH1A1TSHR
SCHEMBL1588934 0.73 ADRB2 (0.47) ADRB2ADRB1CYP3A4CYP2D6NFKB1
SCHEMBL13145152 0.73 ADRB2 (0.47) ADRB2ADRB1CYP3A4CYP2D6NFKB1
SCHEMBL2400168 0.73 HSD11B1 (0.44) HSD11B1CYP3A4CYP1A2LMNAALDH1A1
SCHEMBL2404367 0.73 HSD11B1 (0.44) HSD11B1CYP3A4ALDH1A1IDO1TDO2
SCHEMBL4199089 0.73 GABRA1 (0.60) CYP3A4CYP2D6NFKB1CYP1A2LMNA
SCHEMBL24725717 0.71 ADRB2 (0.46) ADRB2ADRB1CYP3A4CYP2D6NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835427-B2 Fungicidal heterocyclic compounds E I DU PONT DE NEMOURS AND COMPANY (US) 2014-09-16 US disclosed
EP-2358709-B1 FUNGICIDAL HETEROCYCLIC COMPOUNDS DU PONT (US) 2014-01-22 EP disclosed
US-8618137-B2 Fungicidal heterocyclic compounds E I DU PONT DE NEMOURS AND COMPANY (US) 2013-12-31 US disclosed
US-20120309752-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS E I DU PONT DE NEMOURS AND COMPANY (US) 2012-12-06 US disclosed
US-20110224258-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS E.I. DU PONT DE NEMOURS AND COMPANY (DE) 2011-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224258-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS NOX1, XDH, CBR1 HSD11B1 426/4885ADRB2 2268/4885ADRB1 1203/4885
US-20120309752-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS CYP1B1, NOX3, CYP1A1 HSD11B1 424/4885ADRB2 2884/4885ADRB1 2310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.